Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
116.1 USD | -1.70% | -2.25% | -6.73% |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 46.96B |
---|---|---|---|---|---|
Net income 2024 * | 728M | Net income 2025 * | 906M | EV / Sales 2024 * | 11.2 x |
Net Debt 2024 * | 1.43B | Net Debt 2025 * | 994M | EV / Sales 2025 * | 9.31 x |
P/E ratio 2024 * |
65.4
x | P/E ratio 2025 * |
53.4
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.62% |
Latest transcript on DexCom, Inc.
1 day | +1.21% | ||
1 week | -7.49% | ||
Current month | -0.58% | ||
1 month | -8.02% | ||
3 months | -3.04% | ||
6 months | +0.75% | ||
Current year | -4.84% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 17 M€ | +8.17% | - | |
1.04% | 14 M€ | -3.05% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 115.7 | -2.00% | 1 696 041 |
24-06-05 | 118.1 | +1.17% | 3,873,946 |
24-06-04 | 116.7 | +1.28% | 2,904,439 |
24-06-03 | 115.2 | -2.98% | 4,058,266 |
24-05-31 | 118.8 | +0.31% | 6,065,571 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.84% | 46.96B | |
-6.21% | 180B | |
-0.08% | 108B | |
-3.09% | 68.29B | |
+12.85% | 45.64B | |
+7.77% | 42.41B | |
+19.71% | 31.01B | |
+16.55% | 25.51B | |
-7.44% | 23.17B | |
-9.78% | 23.14B |
- Stock Market
- Equities
- DXCM Stock